Scientists are increasingly certain that Alzheimer’s and other dementias are caused by many factors. Genetics certainly play a major role, but researchers are increasingly…
When it comes to Alzheimer’s, what happens first: beta amyloid plaques, or the visible personality and cognitive changes common with the disease? Researchers have…
If you needed more motivation to get moving in the new year, a new study provides more evidence that exercise can help keep your…
Much of Alzheimer’s research has focused on beta-amyloid plaques, one of the main drivers behind neurodegeneration in people with dementia. But more and more…
With repeated drug failures to treat Alzheimer’s disease in recent years, scientists are racing to find a vaccine to prevent the disease from evolving….
Chinese officials announced conditional approval to a seaweed-based drug in November. Now, it’s available on the Chinese market. Oligomannate is the first drug to…
The exact causes behind dementia are varied and at times unclear. We know that genetic factors — like carrying the APOE4 gene — can…
Having conversations about end of life care is difficult at any age, but for seniors, it can be especially difficult. Facing your mortality is…
“My mom died peacefully this afternoon after a decade-long battle with Alzheimer’s and dementia,” professional skateboarder Tony Hawk, 51, wrote on his Facebook page…
Talk with an Alzheimer’s researcher and you’ll likely hear the same lament: Finding a treatment or cure is incredibly challenging because scientists are not…
The party was unremarkable. Overcrowded, yes, but nothing out of the ordinary. Within 15 minutes, however, I began to feel uncomfortable and knew that…
As research into a cure — or at least treatment — for Alzheimer’s continues, scientists are looking beyond the pathways of targeting tau or…
Hundreds of thousands of people die each year from Alzheimer’s. Unfortunately very little is publicly known about them. Typically only their friends and loved…
Biogen announced this week that it was cancelling the dementia drug it was testing in a Phase 2 trial that aimed to fight tau…
Congressional leaders gave the Alzheimer’s and dementia communities an early holiday present this week, announcing an additional $350 million annual appropriation for research into…